The oncogenic point mutation found in p185neu has not been found associated with human neoplasia, but the human p185erbB2/neu protein is overexpressed in a variety of adenocarcinomas typically as a result of erbB2/neu gene amplification. This evidence concerns the gene ERBB2 and adenocarcinoma.